The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Companion Diagnostic Technologies Market Research Report 2025

Global Companion Diagnostic Technologies Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1930939

No of Pages : 86

Ask Your Query

Synopsis

Companion diagnostics are in-vitro diagnostics that provide information about therapeutic responses of patients for a specific treatment.

The global Companion Diagnostic Technologies market was valued at US$ 2771.3 million in 2023 and is anticipated to reach US$ 6057.7 million by 2030, witnessing a CAGR of 11.3% during the forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Companion Diagnostic Technologies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Companion Diagnostic Technologies.

Report Scope

The Companion Diagnostic Technologies market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Companion Diagnostic Technologies market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Companion Diagnostic Technologies companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

  • Dako (Agilent Technologies)
  • Qiagen
  • Roche
  • Abbott Laboratories
  • Thermo Fisher Scientific
  • bioMerieux
  • Myriad Genetics
  • Resonance Health Ltd.
  • Leica Microsystems
  • Danaher

Segment by Type

  • Immunohistochemistry
  • Molecular Diagnostics

Segment by Application

  • Oncology
  • Cardiovascular
  • Central Nervous System
  • Auto immune & Inflammation
  • Virology
  • Others

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Netherlands)
  • Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
  • Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey) 

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Companion Diagnostic Technologies companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Companion Diagnostic Technologies Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Immunohistochemistry
1.2.3 Molecular Diagnostics
1.3 Market by Application
1.3.1 Global Companion Diagnostic Technologies Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Oncology
1.3.3 Cardiovascular
1.3.4 Central Nervous System
1.3.5 Auto immune & Inflammation
1.3.6 Virology
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Companion Diagnostic Technologies Market Perspective (2019-2030)
2.2 Companion Diagnostic Technologies Growth Trends by Region
2.2.1 Global Companion Diagnostic Technologies Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Companion Diagnostic Technologies Historic Market Size by Region (2019-2024)
2.2.3 Companion Diagnostic Technologies Forecasted Market Size by Region (2025-2030)
2.3 Companion Diagnostic Technologies Market Dynamics
2.3.1 Companion Diagnostic Technologies Industry Trends
2.3.2 Companion Diagnostic Technologies Market Drivers
2.3.3 Companion Diagnostic Technologies Market Challenges
2.3.4 Companion Diagnostic Technologies Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Companion Diagnostic Technologies Players by Revenue
3.1.1 Global Top Companion Diagnostic Technologies Players by Revenue (2019-2024)
3.1.2 Global Companion Diagnostic Technologies Revenue Market Share by Players (2019-2024)
3.2 Global Companion Diagnostic Technologies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Companion Diagnostic Technologies Revenue
3.4 Global Companion Diagnostic Technologies Market Concentration Ratio
3.4.1 Global Companion Diagnostic Technologies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Companion Diagnostic Technologies Revenue in 2023
3.5 Companion Diagnostic Technologies Key Players Head office and Area Served
3.6 Key Players Companion Diagnostic Technologies Product Solution and Service
3.7 Date of Enter into Companion Diagnostic Technologies Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Companion Diagnostic Technologies Breakdown Data by Type
4.1 Global Companion Diagnostic Technologies Historic Market Size by Type (2019-2024)
4.2 Global Companion Diagnostic Technologies Forecasted Market Size by Type (2025-2030)
5 Companion Diagnostic Technologies Breakdown Data by Application
5.1 Global Companion Diagnostic Technologies Historic Market Size by Application (2019-2024)
5.2 Global Companion Diagnostic Technologies Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Companion Diagnostic Technologies Market Size (2019-2030)
6.2 North America Companion Diagnostic Technologies Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Companion Diagnostic Technologies Market Size by Country (2019-2024)
6.4 North America Companion Diagnostic Technologies Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Companion Diagnostic Technologies Market Size (2019-2030)
7.2 Europe Companion Diagnostic Technologies Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Companion Diagnostic Technologies Market Size by Country (2019-2024)
7.4 Europe Companion Diagnostic Technologies Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Companion Diagnostic Technologies Market Size (2019-2030)
8.2 Asia-Pacific Companion Diagnostic Technologies Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Companion Diagnostic Technologies Market Size by Region (2019-2024)
8.4 Asia-Pacific Companion Diagnostic Technologies Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Companion Diagnostic Technologies Market Size (2019-2030)
9.2 Latin America Companion Diagnostic Technologies Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Companion Diagnostic Technologies Market Size by Country (2019-2024)
9.4 Latin America Companion Diagnostic Technologies Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Companion Diagnostic Technologies Market Size (2019-2030)
10.2 Middle East & Africa Companion Diagnostic Technologies Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Companion Diagnostic Technologies Market Size by Country (2019-2024)
10.4 Middle East & Africa Companion Diagnostic Technologies Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Dako (Agilent Technologies)
11.1.1 Dako (Agilent Technologies) Company Detail
11.1.2 Dako (Agilent Technologies) Business Overview
11.1.3 Dako (Agilent Technologies) Companion Diagnostic Technologies Introduction
11.1.4 Dako (Agilent Technologies) Revenue in Companion Diagnostic Technologies Business (2019-2024)
11.1.5 Dako (Agilent Technologies) Recent Development
11.2 Qiagen
11.2.1 Qiagen Company Detail
11.2.2 Qiagen Business Overview
11.2.3 Qiagen Companion Diagnostic Technologies Introduction
11.2.4 Qiagen Revenue in Companion Diagnostic Technologies Business (2019-2024)
11.2.5 Qiagen Recent Development
11.3 Roche
11.3.1 Roche Company Detail
11.3.2 Roche Business Overview
11.3.3 Roche Companion Diagnostic Technologies Introduction
11.3.4 Roche Revenue in Companion Diagnostic Technologies Business (2019-2024)
11.3.5 Roche Recent Development
11.4 Abbott Laboratories
11.4.1 Abbott Laboratories Company Detail
11.4.2 Abbott Laboratories Business Overview
11.4.3 Abbott Laboratories Companion Diagnostic Technologies Introduction
11.4.4 Abbott Laboratories Revenue in Companion Diagnostic Technologies Business (2019-2024)
11.4.5 Abbott Laboratories Recent Development
11.5 Thermo Fisher Scientific
11.5.1 Thermo Fisher Scientific Company Detail
11.5.2 Thermo Fisher Scientific Business Overview
11.5.3 Thermo Fisher Scientific Companion Diagnostic Technologies Introduction
11.5.4 Thermo Fisher Scientific Revenue in Companion Diagnostic Technologies Business (2019-2024)
11.5.5 Thermo Fisher Scientific Recent Development
11.6 bioMerieux
11.6.1 bioMerieux Company Detail
11.6.2 bioMerieux Business Overview
11.6.3 bioMerieux Companion Diagnostic Technologies Introduction
11.6.4 bioMerieux Revenue in Companion Diagnostic Technologies Business (2019-2024)
11.6.5 bioMerieux Recent Development
11.7 Myriad Genetics
11.7.1 Myriad Genetics Company Detail
11.7.2 Myriad Genetics Business Overview
11.7.3 Myriad Genetics Companion Diagnostic Technologies Introduction
11.7.4 Myriad Genetics Revenue in Companion Diagnostic Technologies Business (2019-2024)
11.7.5 Myriad Genetics Recent Development
11.8 Resonance Health Ltd.
11.8.1 Resonance Health Ltd. Company Detail
11.8.2 Resonance Health Ltd. Business Overview
11.8.3 Resonance Health Ltd. Companion Diagnostic Technologies Introduction
11.8.4 Resonance Health Ltd. Revenue in Companion Diagnostic Technologies Business (2019-2024)
11.8.5 Resonance Health Ltd. Recent Development
11.9 Leica Microsystems
11.9.1 Leica Microsystems Company Detail
11.9.2 Leica Microsystems Business Overview
11.9.3 Leica Microsystems Companion Diagnostic Technologies Introduction
11.9.4 Leica Microsystems Revenue in Companion Diagnostic Technologies Business (2019-2024)
11.9.5 Leica Microsystems Recent Development
11.10 Danaher
11.10.1 Danaher Company Detail
11.10.2 Danaher Business Overview
11.10.3 Danaher Companion Diagnostic Technologies Introduction
11.10.4 Danaher Revenue in Companion Diagnostic Technologies Business (2019-2024)
11.10.5 Danaher Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables

List of Tables
Table 1. Global Companion Diagnostic Technologies Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Immunohistochemistry
Table 3. Key Players of Molecular Diagnostics
Table 4. Global Companion Diagnostic Technologies Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Companion Diagnostic Technologies Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Companion Diagnostic Technologies Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Companion Diagnostic Technologies Market Share by Region (2019-2024)
Table 8. Global Companion Diagnostic Technologies Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Companion Diagnostic Technologies Market Share by Region (2025-2030)
Table 10. Companion Diagnostic Technologies Market Trends
Table 11. Companion Diagnostic Technologies Market Drivers
Table 12. Companion Diagnostic Technologies Market Challenges
Table 13. Companion Diagnostic Technologies Market Restraints
Table 14. Global Companion Diagnostic Technologies Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Companion Diagnostic Technologies Market Share by Players (2019-2024)
Table 16. Global Top Companion Diagnostic Technologies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Companion Diagnostic Technologies as of 2023)
Table 17. Ranking of Global Top Companion Diagnostic Technologies Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Companion Diagnostic Technologies Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Companion Diagnostic Technologies Product Solution and Service
Table 21. Date of Enter into Companion Diagnostic Technologies Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Companion Diagnostic Technologies Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Companion Diagnostic Technologies Revenue Market Share by Type (2019-2024)
Table 25. Global Companion Diagnostic Technologies Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Companion Diagnostic Technologies Revenue Market Share by Type (2025-2030)
Table 27. Global Companion Diagnostic Technologies Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Companion Diagnostic Technologies Revenue Market Share by Application (2019-2024)
Table 29. Global Companion Diagnostic Technologies Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Companion Diagnostic Technologies Revenue Market Share by Application (2025-2030)
Table 31. North America Companion Diagnostic Technologies Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Companion Diagnostic Technologies Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Companion Diagnostic Technologies Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Companion Diagnostic Technologies Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Companion Diagnostic Technologies Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Companion Diagnostic Technologies Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Companion Diagnostic Technologies Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Companion Diagnostic Technologies Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Companion Diagnostic Technologies Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Companion Diagnostic Technologies Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Companion Diagnostic Technologies Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Companion Diagnostic Technologies Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Companion Diagnostic Technologies Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Companion Diagnostic Technologies Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Companion Diagnostic Technologies Market Size by Country (2025-2030) & (US$ Million)
Table 46. Dako (Agilent Technologies) Company Detail
Table 47. Dako (Agilent Technologies) Business Overview
Table 48. Dako (Agilent Technologies) Companion Diagnostic Technologies Product
Table 49. Dako (Agilent Technologies) Revenue in Companion Diagnostic Technologies Business (2019-2024) & (US$ Million)
Table 50. Dako (Agilent Technologies) Recent Development
Table 51. Qiagen Company Detail
Table 52. Qiagen Business Overview
Table 53. Qiagen Companion Diagnostic Technologies Product
Table 54. Qiagen Revenue in Companion Diagnostic Technologies Business (2019-2024) & (US$ Million)
Table 55. Qiagen Recent Development
Table 56. Roche Company Detail
Table 57. Roche Business Overview
Table 58. Roche Companion Diagnostic Technologies Product
Table 59. Roche Revenue in Companion Diagnostic Technologies Business (2019-2024) & (US$ Million)
Table 60. Roche Recent Development
Table 61. Abbott Laboratories Company Detail
Table 62. Abbott Laboratories Business Overview
Table 63. Abbott Laboratories Companion Diagnostic Technologies Product
Table 64. Abbott Laboratories Revenue in Companion Diagnostic Technologies Business (2019-2024) & (US$ Million)
Table 65. Abbott Laboratories Recent Development
Table 66. Thermo Fisher Scientific Company Detail
Table 67. Thermo Fisher Scientific Business Overview
Table 68. Thermo Fisher Scientific Companion Diagnostic Technologies Product
Table 69. Thermo Fisher Scientific Revenue in Companion Diagnostic Technologies Business (2019-2024) & (US$ Million)
Table 70. Thermo Fisher Scientific Recent Development
Table 71. bioMerieux Company Detail
Table 72. bioMerieux Business Overview
Table 73. bioMerieux Companion Diagnostic Technologies Product
Table 74. bioMerieux Revenue in Companion Diagnostic Technologies Business (2019-2024) & (US$ Million)
Table 75. bioMerieux Recent Development
Table 76. Myriad Genetics Company Detail
Table 77. Myriad Genetics Business Overview
Table 78. Myriad Genetics Companion Diagnostic Technologies Product
Table 79. Myriad Genetics Revenue in Companion Diagnostic Technologies Business (2019-2024) & (US$ Million)
Table 80. Myriad Genetics Recent Development
Table 81. Resonance Health Ltd. Company Detail
Table 82. Resonance Health Ltd. Business Overview
Table 83. Resonance Health Ltd. Companion Diagnostic Technologies Product
Table 84. Resonance Health Ltd. Revenue in Companion Diagnostic Technologies Business (2019-2024) & (US$ Million)
Table 85. Resonance Health Ltd. Recent Development
Table 86. Leica Microsystems Company Detail
Table 87. Leica Microsystems Business Overview
Table 88. Leica Microsystems Companion Diagnostic Technologies Product
Table 89. Leica Microsystems Revenue in Companion Diagnostic Technologies Business (2019-2024) & (US$ Million)
Table 90. Leica Microsystems Recent Development
Table 91. Danaher Company Detail
Table 92. Danaher Business Overview
Table 93. Danaher Companion Diagnostic Technologies Product
Table 94. Danaher Revenue in Companion Diagnostic Technologies Business (2019-2024) & (US$ Million)
Table 95. Danaher Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Companion Diagnostic Technologies Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Companion Diagnostic Technologies Market Share by Type: 2023 VS 2030
Figure 3. Immunohistochemistry Features
Figure 4. Molecular Diagnostics Features
Figure 5. Global Companion Diagnostic Technologies Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Companion Diagnostic Technologies Market Share by Application: 2023 VS 2030
Figure 7. Oncology Case Studies
Figure 8. Cardiovascular Case Studies
Figure 9. Central Nervous System Case Studies
Figure 10. Auto immune & Inflammation Case Studies
Figure 11. Virology Case Studies
Figure 12. Others Case Studies
Figure 13. Companion Diagnostic Technologies Report Years Considered
Figure 14. Global Companion Diagnostic Technologies Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 15. Global Companion Diagnostic Technologies Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Companion Diagnostic Technologies Market Share by Region: 2023 VS 2030
Figure 17. Global Companion Diagnostic Technologies Market Share by Players in 2023
Figure 18. Global Top Companion Diagnostic Technologies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Companion Diagnostic Technologies as of 2023)
Figure 19. The Top 10 and 5 Players Market Share by Companion Diagnostic Technologies Revenue in 2023
Figure 20. North America Companion Diagnostic Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. North America Companion Diagnostic Technologies Market Share by Country (2019-2030)
Figure 22. United States Companion Diagnostic Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Canada Companion Diagnostic Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Companion Diagnostic Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Companion Diagnostic Technologies Market Share by Country (2019-2030)
Figure 26. Germany Companion Diagnostic Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. France Companion Diagnostic Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. U.K. Companion Diagnostic Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Italy Companion Diagnostic Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Russia Companion Diagnostic Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Nordic Countries Companion Diagnostic Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Companion Diagnostic Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Companion Diagnostic Technologies Market Share by Region (2019-2030)
Figure 34. China Companion Diagnostic Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Japan Companion Diagnostic Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. South Korea Companion Diagnostic Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Southeast Asia Companion Diagnostic Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. India Companion Diagnostic Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Australia Companion Diagnostic Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Companion Diagnostic Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Companion Diagnostic Technologies Market Share by Country (2019-2030)
Figure 42. Mexico Companion Diagnostic Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Brazil Companion Diagnostic Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Companion Diagnostic Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Companion Diagnostic Technologies Market Share by Country (2019-2030)
Figure 46. Turkey Companion Diagnostic Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Saudi Arabia Companion Diagnostic Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Dako (Agilent Technologies) Revenue Growth Rate in Companion Diagnostic Technologies Business (2019-2024)
Figure 49. Qiagen Revenue Growth Rate in Companion Diagnostic Technologies Business (2019-2024)
Figure 50. Roche Revenue Growth Rate in Companion Diagnostic Technologies Business (2019-2024)
Figure 51. Abbott Laboratories Revenue Growth Rate in Companion Diagnostic Technologies Business (2019-2024)
Figure 52. Thermo Fisher Scientific Revenue Growth Rate in Companion Diagnostic Technologies Business (2019-2024)
Figure 53. bioMerieux Revenue Growth Rate in Companion Diagnostic Technologies Business (2019-2024)
Figure 54. Myriad Genetics Revenue Growth Rate in Companion Diagnostic Technologies Business (2019-2024)
Figure 55. Resonance Health Ltd. Revenue Growth Rate in Companion Diagnostic Technologies Business (2019-2024)
Figure 56. Leica Microsystems Revenue Growth Rate in Companion Diagnostic Technologies Business (2019-2024)
Figure 57. Danaher Revenue Growth Rate in Companion Diagnostic Technologies Business (2019-2024)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock